AL
ALURW
ALLURION TECHNOLOGIES, INC.
No data for this timeframe.
Vol
Inst. Holders2 funds
Inst. Value$815.00
Inst. Activity1 buys / 1 sells
SEC Reports1
Recent Activity
May 27, 2026
SEC
Allurion Technologies dismissed Deloitte & Touche as its independent auditor and appointed CBIZ CPAs P.C. effective May
8-K — Impact 6/10
Inst.
CITADEL ADVISORS LLC — TRIM
25,160 shares ($755.00)
Inst.
UBS Group AG — DOUBLED
2,012 shares ($60.00)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CITADEL ADVISORS LLC | $755.00 | TRIM |
| UBS Group AG | $60.00 | DOUBLED |
2 institutional holders with $815.00 total value (27,172 shares) as of 2024-Q4. Top holders: CITADEL, UBS.
Top Institutional Holders — 2024-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 25,160 | $755.00 | 92.6% | TRIM -62.6% |
| 2 | UBS Group AG | 2,012 | $60.00 | 7.4% | DOUBLED +542.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | TRIM | 67,258 | 25,160 | -62.6% | $755.00 | 2024-Q4 |
| UBS Group AG | DOUBLED | 313 | 2,012 | +542.8% | $60.00 | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -2.3% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 35.4% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -10.1% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | 520.4% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.